TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Diabetes Care Drugs Market, Global Outlook and Forecast 2022-2028

Diabetes Care Drugs Market, Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 30 July 2022
  • Pages :62
  • Formats:
  • Report Code:SMR-7245097
OfferClick for best price

Best Price: $2600

Diabetes Care Drugs Market Size, Share 2022


Diabetes is a group of metabolic diseases characterized by hyperglycemia. HYPERGLYCEMIA is caused by defective insulin secretion or impaired biological function, or both. The long-term existence of high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.Diabetes care drugs are used to treat diabetes.

This report contains market size and forecasts of Diabetes Care Drugs in Global, including the following market information:

Global top five companies in 2021 (%)

The global Diabetes Care Drugs market was valued at 67200 million in 2021 and is projected to reach US$ 95620 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Anti-diabetic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetes Care Drugs include Novo Nordisk, Sanofi, Eli Lilly, Biocon, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Mylan and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Diabetes Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetes Care Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Care Drugs Market Segment Percentages, by Type, 2021 (%)

  • Oral Anti-diabetic Drugs
  • Insulins
  • Non-insulin Injectable Drugs
  • Other

Global Diabetes Care Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Care Drugs Market Segment Percentages, by Application, 2021 (%)

  • Hospital
  • Medical Research Institute
  • Clinic
  • Other

Global Diabetes Care Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetes Care Drugs Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Diabetes Care Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Diabetes Care Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Biocon
  • AstraZeneca
  • Bristol Myers Squibb
  • Boehringer Ingelheim
  • Mylan
  • Pfizer
  • Johnson & Johnson
  • Merck
  • Novartis
  • Astellas
  • Teva

Report Attributes Report Details
Report Title Diabetes Care Drugs Market, Global Outlook and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 62 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Diabetes Care Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Care Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Care Drugs Overall Market Size
2.1 Global Diabetes Care Drugs Market Size: 2021 VS 2028
2.2 Global Diabetes Care Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Care Drugs Players in Global Market
3.2 Top Global Diabetes Care Drugs Companies Ranked by Revenue
3.3 Global Diabetes Care Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Care Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetes Care Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Care Drugs Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Care Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Care Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Diabetes Care Drugs Market Size Markets, 2021 & 2028
4.1.2 Oral Anti-diabetic Drugs
4.1.3 Insulins
4.1.4 Non-insulin Injectable Drugs
4.1.5 Other
4.2 By Type - Global Diabetes Care Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetes Care Drugs Revenue, 2017-2022
4.2.2 By Type - Global Diabetes Care Drugs Revenue, 2023-2028
4.2.3 By Type - Global Diabetes Care Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Care Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Medical Research Institute
5.1.4 Clinic
5.1.5 Other
5.2 By Application - Global Diabetes Care Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetes Care Drugs Revenue, 2017-2022
5.2.2 By Application - Global Diabetes Care Drugs Revenue, 2023-2028
5.2.3 By Application - Global Diabetes Care Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Diabetes Care Drugs Market Size, 2021 & 2028
6.2 By Region - Global Diabetes Care Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetes Care Drugs Revenue, 2017-2022
6.2.2 By Region - Global Diabetes Care Drugs Revenue, 2023-2028
6.2.3 By Region - Global Diabetes Care Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diabetes Care Drugs Revenue, 2017-2028
6.3.2 US Diabetes Care Drugs Market Size, 2017-2028
6.3.3 Canada Diabetes Care Drugs Market Size, 2017-2028
6.3.4 Mexico Diabetes Care Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diabetes Care Drugs Revenue, 2017-2028
6.4.2 Germany Diabetes Care Drugs Market Size, 2017-2028
6.4.3 France Diabetes Care Drugs Market Size, 2017-2028
6.4.4 U.K. Diabetes Care Drugs Market Size, 2017-2028
6.4.5 Italy Diabetes Care Drugs Market Size, 2017-2028
6.4.6 Russia Diabetes Care Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Diabetes Care Drugs Market Size, 2017-2028
6.4.8 Benelux Diabetes Care Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diabetes Care Drugs Revenue, 2017-2028
6.5.2 China Diabetes Care Drugs Market Size, 2017-2028
6.5.3 Japan Diabetes Care Drugs Market Size, 2017-2028
6.5.4 South Korea Diabetes Care Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Diabetes Care Drugs Market Size, 2017-2028
6.5.6 India Diabetes Care Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diabetes Care Drugs Revenue, 2017-2028
6.6.2 Brazil Diabetes Care Drugs Market Size, 2017-2028
6.6.3 Argentina Diabetes Care Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Care Drugs Revenue, 2017-2028
6.7.2 Turkey Diabetes Care Drugs Market Size, 2017-2028
6.7.3 Israel Diabetes Care Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Diabetes Care Drugs Market Size, 2017-2028
6.7.5 UAE Diabetes Care Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Diabetes Care Drugs Major Product Offerings
7.1.4 Novo Nordisk Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.1.5 Novo Nordisk Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Diabetes Care Drugs Major Product Offerings
7.2.4 Sanofi Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Diabetes Care Drugs Major Product Offerings
7.3.4 Eli Lilly Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly Key News
7.4 Biocon
7.4.1 Biocon Corporate Summary
7.4.2 Biocon Business Overview
7.4.3 Biocon Diabetes Care Drugs Major Product Offerings
7.4.4 Biocon Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.4.5 Biocon Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Diabetes Care Drugs Major Product Offerings
7.5.4 AstraZeneca Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Corporate Summary
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Diabetes Care Drugs Major Product Offerings
7.6.4 Bristol Myers Squibb Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.6.5 Bristol Myers Squibb Key News
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporate Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Diabetes Care Drugs Major Product Offerings
7.7.4 Boehringer Ingelheim Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.7.5 Boehringer Ingelheim Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Diabetes Care Drugs Major Product Offerings
7.8.4 Mylan Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.8.5 Mylan Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Diabetes Care Drugs Major Product Offerings
7.9.4 Pfizer Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Diabetes Care Drugs Major Product Offerings
7.10.4 Johnson & Johnson Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.10.5 Johnson & Johnson Key News
7.11 Merck
7.11.1 Merck Corporate Summary
7.11.2 Merck Business Overview
7.11.3 Merck Diabetes Care Drugs Major Product Offerings
7.11.4 Merck Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.11.5 Merck Key News
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Business Overview
7.12.3 Novartis Diabetes Care Drugs Major Product Offerings
7.12.4 Novartis Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.12.5 Novartis Key News
7.13 Astellas
7.13.1 Astellas Corporate Summary
7.13.2 Astellas Business Overview
7.13.3 Astellas Diabetes Care Drugs Major Product Offerings
7.13.4 Astellas Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.13.5 Astellas Key News
7.14 Teva
7.14.1 Teva Corporate Summary
7.14.2 Teva Business Overview
7.14.3 Teva Diabetes Care Drugs Major Product Offerings
7.14.4 Teva Diabetes Care Drugs Revenue in Global Market (2017-2022)
7.14.5 Teva Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES



REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount